Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
How should we choose optimal salvage treatments following BCMA-directed CAR T-cell therapy?
Journal: Immunotherapy
Published: October 17, 2025
Emerging GPRC5D-Targeted therapies for multiple myeloma: a comprehensive review.
Journal: Expert opinion on investigational drugs
Published: May 27, 2025
Design, synthesis and mechanistic exploration of anti-plasmodial Indolo[2,3-b]quinoxaline-7-chloroquinoline hybrids.
Journal: Future medicinal chemistry
Published: November 07, 2024
Web-Based Scaffolds: The Feasibility of a Constructivist Approach to Oncology Fellow Learning.
Journal: JMIR cancer
Published: September 05, 2023
Impact of corticosteroids on efficacy of BCMA targeted CAR-T therapy in multiple myeloma.
Journal: Leukemia & lymphoma
Published: August 21, 2023
Significance of the pee-value: relevance of 24-hour urine studies for patients with myeloma.
Journal: Leukemia & lymphoma
Published: April 25, 2023
Randomized phase 2 study of digital life coaching during transplantation for myeloma.
Journal: Bone marrow transplantation
Published: March 28, 2023
Intensity of Cyclophosphamide-Based Bridging Therapy Before Chimeric Antigen Receptor T Cell Therapy in Myeloma.
Journal: Transplantation and cellular therapy
Published: February 04, 2023
Safety and Efficacy of BCMA CAR-T Cell Therapy in Older Patients With Multiple Myeloma.
Journal: Transplantation and cellular therapy
Published: January 26, 2023
Daratumumab Plus Bortezomib and Dexamethasone in Newly Diagnosed Systemic Light Chain Amyloidosis.
Journal: Current problems in cancer
Published: November 20, 2022
Last Updated: 09/26/2026